Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Dec 28, 2005; 11(48): 7639-7645
Published online Dec 28, 2005. doi: 10.3748/wjg.v11.i48.7639
Published online Dec 28, 2005. doi: 10.3748/wjg.v11.i48.7639
Active UC (n = 34) | Inactive UC (n = 12) | |
Male/female | 22/12 | 8/4 |
Age (yr) | 41.5±14.6 (17–73) | 42.8±15.2 (18–65) |
Extent of disease | ||
Rectosigmoiditis | 6 | 3 |
Left-sided colitis | 20 | 6 |
Pancolitis | 8 | 3 |
SCCAI score | 8±3 (3–12) | 0±1 (0–2) |
Endoscopic score | 16±2 (12–18) | 2±1 (0–3) |
Treatment | ||
Oral steroids | 15 | 0 |
5-ASA compounds | 30 | 12 |
Azathioprine | 11 | 2 |
None | 2 | 0 |
Smoking | 7 | 5 |
- Citation: Zezos P, Papaioannou G, Nikolaidis N, Vasiliadis T, Giouleme O, Evgenidis N. Elevated plasma von Willebrand factor levels in patients with active ulcerative colitis reflect endothelial perturbation due to systemic inflammation. World J Gastroenterol 2005; 11(48): 7639-7645
- URL: https://www.wjgnet.com/1007-9327/full/v11/i48/7639.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i48.7639